Accelerate Cancer Drug Development ‒ Proven Model for Testing the Effectiveness of Immunotherapies

By Noble Life Sciences

The in vivo animal tumour models possessing fully functional immunity are essential for preclinical research of new immunotherapeutic medicine.

Syngeneic tumour models are excellent in vivo animal models meeting the need for preclinical research and development of innovative immunotherapies as their homografts are developed from immortalised mouse tumour cell lines originated from the same inbred mouse strains with fully competent immunity.

To read more, please download this free white paper.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.